After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
West Pharmaceutical Services, Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. The current market capitalization of West Pharmaceutical Services, Inc. is $22.09B. A total of 0.71 million shares were traded on the day, compared to an average of 654.14K shares.
In the most recent transaction, Green Eric Mark bought 30,732 shares of WST for 304.71 per share on Aug 06 ’24. In a previous transaction on Jun 12 ’24, Abraham Silji sold 1,800 shares at 330.78 per share. WST shares that SVP, Chief Technology Officer owns now total 2,860.
Among the insiders who sold shares, Green Eric Mark disposed of 66,000 shares on May 07 ’24 at a per-share price of $366.65. This resulted in the President, CEO and Board Chair holding 152,908 shares of WST after the transaction. In another insider transaction, Winters Chad sold 815 shares at $358.82 per share on Mar 11 ’24. Company shares held by the VP, Chief Accounting Officer now total 1,309.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. West Pharmaceutical Services, Inc. pays an annual dividend of $0.80, resulting in a dividend yield of 0.26%, and it has a price to earnings (P/E) ratio of 43.30. WST’s most recent ex-dividend date was 7/31/2024 when it declared a $0.20 quarterly dividend that was paid in cash on 8/7/2024. Previously, the company paid the dividend on 5/1/2024 with an ex-dividend date of 4/23/2024. The WST stock dividend was $0.20 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, WST has a high of $415.73 and a low of $265.00.
As of this writing, WST has an earnings estimate of $1.5 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $1.57 per share and a lower estimate of $1.46.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. WST’s latest balance sheet shows that the firm has $762.60M in Cash & Short Term Investments as of fiscal 2021. There were $325.30M in debt and $594.10M in liabilities at the time. Its Book Value Per Share was $35.49, while its Total Shareholder’s Equity was $2.34B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for WST is Buy with a score of 4.50.
